The global Orthobiologics Market is valued at $6.56 billion in 2024 and is projected to reach a value of $10.4 billion by ...

Cervical artificial disc replacement (ADR) has transformed the way healthcare professionals treat degenerative disc disease and other spinal conditions. Unlike traditional spinal fusion, ADR preserves ...

Nevro Corp (NYSE:NVRO), a medical device company specializing in spinal cord stimulation (SCS) technology for chronic pain treatment, has recently undergone significant changes in its market position ...

Epidural steroid injections may modestly reduce pain and disability for certain chronic back pain conditions, but their ...

Originating in France in around 700 CE, Basset Hounds are extraordinarily talented. Their ability to pick up scents from far ...

Spinal cord injury (SCI) remains the most serious complication of repairing descending thoracic and thoracoabdominal aortic aneurysms, with endovascular ...

The human body is a key subject of research by scientists worldwide. A biomedical engineering research team led by Professor ...

during tests of experimental spinal cord stimulation to improve muscle function in Pittsburgh, on March 14, 2023. (UPMC, University of Pittsburgh Health Sciences via AP) A spine-stimulating implant ...

Medicare may cover the implantation of a spinal cord stimulator as a therapy for chronic intractable pain. Chronic intractable pain refers to persistent pain that doesn’t respond to traditional ...

Source: FactSet Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. Sources: FactSet ...

The U.S. portion of the deal is expected to close in the first half of this year. “We believe that the spinal implants business, with its comprehensive portfolio and strong sales channel ...